Nike Climbs After Analyst Upgrade and 3 Hot Stocks Turning Heads

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Current Price: $171.90

The company has announced that it received from Sanofi (NYSE:SNY) a notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, stating Sanofi has intentions to acquire Common Stock of Regeneron via open market purchases and direct purchases from shareholders. Because of this, Sanofi intends that the value of its ownership of voting securities of Regeneron stock will exceed the $500 million HSR Act notification threshold.

Markets are off to the races and this stock is on fire. Click here to discover it now!

Capture

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business